A Case of Varicelliform Zoster in a Patient Treated with Etanercept for Ankylosing Spondylitis
Journal of Rheumatic Diseases
;
: 186-189, 2015.
Artigo
em Inglês
| WPRIM
| ID: wpr-36843
ABSTRACT
Tumor necrosis factor-alpha (TNF-alpha) inhibitors are increasingly used in treatment of inflammatory disorders because of their immunomodulatory efficacy. Increased risk of infection is an adverse effect of anti-TNF-alpha therapy. The incidence rate and severity of herpes zoster is significantly higher in patients on anti-TNF-alpha therapy than in the general population. The clinical presentation of varicella zoster virus infection is also often atypical in these patients. We experienced a patient who presented with a disseminated varicelliform rash while on etanercept therapy for ankylosing spondylitis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Espondilite Anquilosante
/
Incidência
/
Fator de Necrose Tumoral alfa
/
Herpesvirus Humano 3
/
Exantema
/
Etanercepte
/
Herpes Zoster
Tipo de estudo:
Estudo de incidência
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Inglês
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2015
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS